Comparing the Velocity of Haloperidol, Chlorpromazine, Trifluoperazine, and Promethazine in Sedating of Aggressive Patients

Document Type : Original Article (s)

Authors

1 Professor, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Resident, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Department of Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Aggression is a threatening hurtful sign occurring by a variety of causes, and should be managed rapidly by therapists. To this end, anti-psychotic drugs are used. It is essential to identify the medications that are more rapidly efficient, and can calm an aggressive patient. This study attempted to compare the velocity of haloperidol, trifluoperazine, promethazine, and chlorpromazine in sedating of aggressive patients.Methods: This was a randomized clinical trial study on aggressive patients referred to the psychiatry emergency department of Nour hospital, Isfahan, Iran, from 2016 to 2017. 76 patients were randomly divided into 4 groups, and respectively received haloperidol, promethazine, chlorpromazine, and trifluoperazine intramuscularly. Patients were evaluated each 30 minutes for aggressive symptoms. The time last for sedation was recorded for each patient, too.Findings: 76 patients with the mean age of 32.85 ± 7.80 years participated in this study, and 61.8% of them were men. 59.2% showed respond to intervention after the first injection, and 40.8% needed the second injection. The mean time needed for obtaining sedation was 19.41 ± 6.61 and 18.71 ± 5.38 minutes after the first and second injection, respectively. These mean times of sedation induction were not significantly related to age, gender, type of substance used, and type of aggression. After the first and second injection, the shortest time needed of sedation induction was in promethazine group and the longest one was in chlorpromazine group.Conclusion: Promethazine has the highest speed in creating sedative effects on aggressive patients. None of the studied drugs produced any side effect.

Keywords

References

  1. Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry 2008; 165(4): 429-42.
  2. Ahmed U, Jones H, Adams CE. Chlorpromazine for psychosis-induced aggression or agitation. Schizophr Bull 2011; 37(5): 890-1.
  3. Berk M, Rathbone J, Mandriota-Carpenter SL. Clotiapine for acute psychotic illnesses. Cochrane Database Syst Rev 2004; (4): CD002304.
  4. Mantovani C, Migon MN, Alheira FV, Del-Be CM. Managing agitated or aggressive patients. Braz J Psychiatry 2010; 32(Suppl II): S96-S103.
  5. Bellnier TJ. Continuum of care: stabilizing the acutely agitated patient. Am J Health Syst Pharm 2002; 59(17 Suppl 5): S12-S18.
  6. Currier GW, Trenton A. Pharmacological treatment of psychotic agitation. CNS Drugs 2002; 16(4): 219-28.
  7. Tardy M, Leucht S, Potapov A, Kissling W, Engel R, Huhn M, et al. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2011; (8): CD009268.
  8. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet 2009; 373(9657): 31-41.
  9. Hartung B, Wada M, Laux G, Leucht S. Perphenazine for schizophrenia. Cochrane Database Syst Rev 2005; (1): CD003443.
  10. Tardy M, Dold M, Engel RR, Leucht S. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2014; (7): CD009396.
  11. Huf G, Coutinho ES, Adams CE. TREC-Rio trial: A randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243]. BMC Psychiatry 2002; 2: 11.
  12. Adolph O, Koster S, Georgieff M, Georgieff EM, Moulig W, Fohr KJ. Promethazine inhibits NMDA-induced currents - new pharmacological aspects of an old drug. Neuropharmacology 2012; 63(2): 280-91.
  13. Baldacara L, Sanches M, Cordeiro DC, Jackoswski AP. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. Braz J Psychiatry 2011; 33(1): 30-9.
  14. Vishne T, Amiaz R, Grunhaus L. Promethazine for the treatment of agitation after electroconvulsive therapy: A case series. J ECT 2005; 21(2): 118-21.
  15. Ingram DG, Hagemann TM. Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother 2003; 37(7-8): 1036-9.
  16. Terndrup TE, Cantor RM, Madden CM. Intramuscular meperidine, promethazine, and chlorpromazine: Analysis of use and complications in 487 pediatric emergency department patients. Ann Emerg Med 1989; 18(5): 528-33.
  17. Ahmed U, Jones H, Adams CE. Chlorpromazine for psychosis induced aggression or agitation. Cochrane Database Syst Rev 2010; (4): .CD003443.
  18. Ritter RM, Davidson DE, Robinson TA. Comparison of injectable haloperidol and chlorpromazine. Am J Psychiatry 1972; 129(1): 78-81.
  19. National Collaborating Centre for Nursing and Supportive Care (UK). Violence: The Short-Term Management of Disturbed/Violent Behaviour in In-Patient Psychiatric Settings and Emergency Departments. London: Royal College of Nursing (UK); 2005.
  20. Marco CA, Vaughan J. Emergency management of agitation in schizophrenia. Am J Emerg Med 2005; 23(6): 767-76.
Journal of Isfahan Medical School
Volume 37, Issue 526 - Serial Number 526
March and April 2019
Pages 500-507

Files

History

  • Receive Date: 29 December 2018
  • Revise Date: 26 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics